Does antimalarial mass drug administration increase or decrease the risk of resistance?

The Lancet Infectious Diseases

Volumn 17, Issue 1, 2017, Pages e15-e20

  White, Nicholas J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ANTIMALARIAL DRUG RESISTANCE; DRUG ADMINISTRATION; HOST RESISTANCE; HUMAN; MALARIA; MASS DRUG ADMINISTRATION; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURVIVAL; ANIMAL; DRUG EFFECTS; DRUG RESISTANCE; INSECT VECTOR; MALARIA, FALCIPARUM; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; HUMANS; INSECT VECTORS; MALARIA, FALCIPARUM; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85006341531     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30269-9     Document Type: Review

References (33)

1. 1 WHO. WHO expert committee on malaria. Fifteenth report. World Health Organ Tech Rep Ser 467 (1971), 1–59.
2. 2 WHO. Consideration of mass drug administration for the containment of artemisinin-resistant malaria in the Greater Mekong subregion, July, 2011, World Health Organization, Geneva http://www.who.int/malaria/publications/atoz/9789241501644/en/ (accessed Sept 1, 2016).
3. 3 von Seidlein, L, Greenwood, BM, Mass administrations of antimalarial drugs. Trends Parasitol 19 (2003), 452–460.
4. 4 Clyde, DF, Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika. Bull World Health Organ 27 (1962), 203–212.
5. 5 Poirot, E, Skarbinski, J, Sinclair, D, Kachur, SP, Slutsker, L, Hwang, J, Mass drug administration for malaria. Cochrane Database Syst Rev, 12, 2013 CD008846.
6. 6 Wootton, JC, Feng, X, Ferdig, MT, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418 (2002), 320–323.
7. 7 White, NJ, Pongtavornpinyo, W, Maude, RJ, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J, 8, 2009, 253.
8. 8 Price, R, Nosten, F, Simpson, JA, et al. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 60 (1999), 1019–1023.
9. 9 Barnes, KI, Little, F, Mabuza, A, et al. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis 197 (2008), 1605–1613.
10. 10 Stepniewska, K, White, NJ, Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother 52 (2008), 1589–1596.
11. 11 Kaneko, A, Taleo, G, Kalkoa, M, Yamar, S, Kobayakawa, T, Björkman, A, Malaria eradication on islands. Lancet 356 (2000), 1560–1564.
12. 12 Tseroni, M, Baka, A, Kapizioni, C, et al. Prevention of malaria resurgence in Greece through the association of mass drug administration (MDA) to immigrants from malaria-endemic regions and standard control measures. PLoS Negl Trop Dis, 9, 2015, e0004215.
13. 13 Newby, G, Hwang, J, Koita, K, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg 93 (2015), 125–134.
14. 14 Deng, C, Wang, Q, Zheng, S, et al. Mass drug administration of artemisinin-piperaquine on high malaria epidemic area. Trop Med Health 42:suppl (2014), 33–41.
15. 15 Kondrashin, A, Baranova, AM, Ashley, EA, Recht, J, White, NJ, Sergiev, VP, Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malar J, 13, 2014, 51.
16. 16 Hsiang, MS, Hwang, J, Tao, AR, et al. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China. Malar J, 12, 2013, 383.
17. 17 Shekalaghe, SA, Drakeley, C, van den Bosch, S, et al. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J, 10, 2011, 247.
18. 18 Song, J, Socheat, D, Tan, B, et al. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J, 9, 2010, 57.
19. 19 von Seidlein, L, Walraven, G, Milligan, PJ, et al. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg 97 (2003), 217–225.
20. 20 Kondrashin, AV, Sanyal, MC, Mass drug administration in Andhra Pradesh in areas under Plasmodium falciparum containment programme. J Commun Dis 17 (1985), 293–299.
21. 21 Lwin, KM, Imwong, M, Suangkanarat, P, et al. Elimination of Plasmodium falciparum in an area of multi-drug resistance. Malar J, 14, 2015, 319.
22. 22 White, NJ, How antimalarial drug resistance affects post-treatment prophylaxis. Malar J, 7, 2008, 9.
23. 23 Watkins, WM, Mosobo, M, Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg 87 (1993), 75–78.
24. 24 Hastings, IM, Ward, SA, Coartem (artemether-lumefantrine) in Africa: the beginning of the end?. J Infect Dis 192 (2005), 1303–1305.
25. 25 Garfield, RM, Vermund, SH, Health education and community participation in mass drug administration for malaria in Nicaragua. Soc Sci Med 22 (1986), 869–877.
26. 26 WHO Division of Malaria Eradication. Guidelines for the use of medicated salt (Pinotti's method) in malaria eradication programmes, 1960, World Health Organization, Geneva.
27. 27 Verdrager, J, Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. J Trop Med Hyg 89 (1986), 277–289.
28. 28 Payne, D, Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?. Parasitol Today 4 (1988), 112–115.
29. 29 WHO. Guidelines for the treatment of malaria, 2016, World Health Organization, Geneva.
30. 30 Clyde, DF, The problem of drug-resistant malaria. Am J Trop Med Hyg 21 (1972), 736–743.
31. 31 Imwong, M, Stepniewska, K, Tripura, R, et al. Numerical distributions of parasite densities in asymptomatic malaria. J Infect Dis 213 (2016), 1322–1329.
32. 32 White, NJ, Antimalarial drug resistance. J Clin Invest 113 (2004), 1084–1092.
33. 33 Phyo, AP, Ashley, EA, Anderson, TJ, et al. Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar border (2003–2013): the role of parasite genetic factors. Clin Infect Dis 63 (2016), 784–791.